Clinical Trial: NCT07588828
EFFECT OF DAFLON (DIOSMIN AND HESPERIDIN) ON POST-OPERATIVE SEROMA FORMATION IN BREAST CANCER SURGERY''
Status:
COMPLETEDPhase:
Phase 4| Lead Sponsor: | Ittefaq Hospital trust |
| Information Provided By: | Ittefaq Hospital trust |
| Last Update Posted: | 2026-05-15 |
Study Overview
Brief Summary
Post-operative seroma formation remains one of the most common complications following breast cancer surgery. This prospective randomized controlled trial was conducted to evaluate the efficacy of Micronized Purified Flavonoid Fraction (Daflon) in reducing post-operative seroma formation in patients undergoing breast cancer surgery with sentinel lymph node biopsy or axillary lymph node dissection.
Official Title
Conditions
Intervention / Treatment
- Drug: Daflon (Diosmin and Hesperidin)
Other Study ID Numbers
- IttefaqH
- AArshad
Start Date (Actual)
Primary Completion Date (Actual)
Study Completion Date (Actual)
Enrollment (Actual)
Study Type
Phase
| Lead Sponsor: | Ittefaq Hospital trust |
| Information Provided By: | Ittefaq Hospital trust |
| Last Update Posted: | 2026-05-15 |
Study Overview
Brief Summary
Post-operative seroma formation remains one of the most common complications following breast cancer surgery. This prospective randomized controlled trial was conducted to evaluate the efficacy of Micronized Purified Flavonoid Fraction (Daflon) in reducing post-operative seroma formation in patients undergoing breast cancer surgery with sentinel lymph node biopsy or axillary lymph node dissection.
Official Title
Conditions
Intervention / Treatment
- Drug: Daflon (Diosmin and Hesperidin)
Other Study ID Numbers
- IttefaqH
- AArshad